daunorubicin has been researched along with Cancer of Prostate in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Biri-Kovács, B; Borbély, A; Bősze, S; Gomena, J; Mező, G; Oláh-Szabó, R; Ranđelović, I; Soós, Á; Tóvári, J; Vári, B | 1 |
| Bache, M; Güttler, A; Haupt, V; Reime, S; Riemann, A; Thews, O; Vordermark, D; Wichmann, H | 1 |
| Chuang, WJ; Fu, WM; Hsieh, IS; Huang, WH; Liou, HC; Yang, RS | 1 |
| Fei, X; Lin, Z; Ma, Q; Su, X; Zhang, H | 1 |
| Barratt, G; Døskeland, SO; Herfindal, L; Myhren, L; Nicolas, V; Nilssen, IM | 1 |
| Castellon, EA; Castillo, V; Contreras, HR; Huidobro, C; Valenzuela, R | 1 |
| Mansilla, S; Portugal, J; Priebe, W; Rodríguez-Sánchez, MA; Vizcaíno, C | 1 |
| Bősze, S; Halmos, G; Kovács, M; Mező, G; Orbán, E; Sipos, É; Szabó, I | 1 |
| Chow, MS; Hao, J; Huang, Y; Lam, CW; Lau, B; Liu, M; Ravula, R; Shi, L; Song, Y; Wang, J; Wang, Z; Yeung, S | 1 |
| Gekle, M; Sauvant, C; Thews, O; Wirth, C | 1 |
| Gekle, M; Nowak, M; Riemann, A; Sauvant, C; Schneider, B; Thews, O; Wirth, C | 1 |
| Deguchi, T; Fujita, Y; Ito, M; Kojima, K; Nozawa, Y | 1 |
| Afahaene, N; Nowak, M; Thews, O; Trach, P | 1 |
| Britigan, BE; Burns, CP; Reszka, KJ; Spitz, DR; Teesch, LM; Wagner, BA | 1 |
| Arcamone, F; Capobianco, ML; Carbone, GM; Catapano, CV; Napoli, S; Negri, U | 1 |
| Bernshausen, A; Bieler, A; Dravits, T; Gansbacher, B; Hartung, R; Holm, PS; Kaszubiak, A; Köhler-Vargas, N; Lage, H; Mantwill, K; Surowiak, P; Treiber, U | 1 |
| Keller, GM; Lu, P; Voelkel-Johnson, C; White, SJ | 1 |
| Morozumi, M; Okada, M; Takasu, H; Watanabe, T | 1 |
| Pavone-Macaluso, M | 1 |
1 review(s) available for daunorubicin and Cancer of Prostate
| Article | Year |
|---|---|
[Primary non-Hodgkin lymphoma of the prostate: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Prednisolone; Prostatectomy; Prostatic Neoplasms; Remission Induction; Vincristine | 1993 |
18 other study(ies) available for daunorubicin and Cancer of Prostate
| Article | Year |
|---|---|
Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide-Drug Conjugates.
Topics: Bombesin; Daunorubicin; Humans; Male; Peptides; Pharmaceutical Preparations; Prostatic Neoplasms; Receptors, Bombesin | 2023 |
Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Daunorubicin; Gene Expression; Humans; Hydrogen-Ion Concentration; Hypoxia; Male; Prostatic Neoplasms | 2018 |
Upregulation of drug transporter expression by osteopontin in prostate cancer cells.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Death; Cell Hypoxia; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Humans; Integrin alphaVbeta3; Male; Mice; Mice, Inbred NOD; Mice, SCID; Osteopontin; Prostatic Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays | 2013 |
A novel aptamer functionalized CuInS2 quantum dots probe for daunorubicin sensing and near infrared imaging of prostate cancer cells.
Topics: Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Line, Tumor; Cell Survival; Copper; Daunorubicin; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Indium; Male; Mucin-1; Prostatic Neoplasms; Quantum Dots; Salts; Spectroscopy, Near-Infrared; Temperature; Time Factors | 2014 |
Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia.
Topics: Anthracyclines; Cell Line, Tumor; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Resistance; Emetine; Flow Cytometry; Folate Receptor 2; Humans; Leukemia, Myeloid, Acute; Light; Liposomes; Male; Methotrexate; Polyethylene Glycols; Prostatic Neoplasms; Scattering, Radiation; Tumor Suppressor Protein p53 | 2014 |
Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biomarkers, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Indoles; Male; Neoplasm Proteins; Neoplastic Stem Cells; Prostatic Neoplasms; Spheroids, Cellular; Topotecan; Tumor Cells, Cultured | 2014 |
Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Deoxyglucose; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Male; Membrane Proteins; Microtubule-Associated Proteins; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Sequestosome-1 Protein; Time Factors; Tumor Suppressor Protein p53 | 2015 |
Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Gonadotropin-Releasing Hormone; HT29 Cells; Humans; Male; MCF-7 Cells; Pituitary Neoplasms; Prostatic Neoplasms; Receptors, LHRH | 2015 |
Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Survival; Daunorubicin; Docetaxel; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Male; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Plant Extracts; Prostatic Neoplasms; Taxoids; Tripterygium | 2016 |
Direct determination of intracellular daunorubicin in intact confluent monolayers of AT1 prostate carcinoma cells using a multiwell-multilabel counter.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Extracts; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Analytical; Daunorubicin; DNA, Neoplasm; Intracellular Space; Male; Prostatic Neoplasms; Rats; Spectrometry, Fluorescence; Subcellular Fractions; Time Factors; Verapamil | 2008 |
Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38.
Topics: Acidosis; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 3; Cell Proliferation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hydrogen-Ion Concentration; Male; Neoplasm Transplantation; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Kinase C; Rats | 2008 |
MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Topics: 3' Untranslated Regions; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Daunorubicin; DNA Primers; Drug Resistance, Neoplasm; Etoposide; Humans; Male; MicroRNAs; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sirtuin 1; Tumor Suppressor Protein p53 | 2010 |
Impact of environmental parameters on the activity of the P-glycoprotein.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 3; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Male; Prostatic Neoplasms; Protein Transport; Rats; Reactive Oxygen Species; Tumor Microenvironment | 2012 |
Inactivation of anthracyclines by cellular peroxidase.
Topics: Animals; Antibiotics, Antineoplastic; Biotransformation; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Male; Myocytes, Cardiac; Oxidation-Reduction; Peroxidase; Phthalic Acids; Prostatic Neoplasms; Rats; Salicylates | 2005 |
Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line, Tumor; Daunorubicin; Genes, myc; Growth Inhibitors; Humans; Male; Oligonucleotides; Promoter Regions, Genetic; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Transcription, Genetic | 2006 |
Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.
Topics: Adenoviridae; Adenovirus E2 Proteins; Animals; Antineoplastic Agents; Cell Nucleus; Combined Modality Therapy; Daunorubicin; DNA-Binding Proteins; Docetaxel; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, MDR; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Nuclear Proteins; Oncolytic Virotherapy; Promoter Regions, Genetic; Prostatic Neoplasms; Taxoids; Virus Replication; Xenograft Model Antitumor Assays; Y-Box-Binding Protein 1 | 2006 |
Targeting the short form of cFLIP by RNA interference is sufficient to enhance TRAIL sensitivity in PC3 prostate carcinoma cells.
Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Daunorubicin; DNA Primers; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Transfection | 2006 |
Chemotherapy of vesical and prostatic tumours.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Cobalt Isotopes; Cystitis; Daunorubicin; Ethoglucid; Fluorouracil; Humans; Hydroxyurea; Male; Methotrexate; Mitomycins; Nitrogen Mustard Compounds; Papilloma; Prostatic Neoplasms; Thiotepa; Urinary Bladder Neoplasms | 1971 |